An ounce of prevention is worth a pound of cure, according to Ben Franklin. But what if the prevention causes more harm than benefit? And what if the prevention doesn't prevent much of anything at all?

LONDON, January 14 /PRNewswire/ -- Yes, it's true - UK children really do prefer the taste of oranges and strawberries over soft-drink flavours like fizzy cola.

That's just one of the findings to be announced at the Formulating Better Medicines for Children conference, the first event of its kind to draw together Europe's experts on the design, manufacture, delivery and thinking behind paediatric medicine.

Hosted by the Royal Pharmaceutical Society of Great Britain (RPSGB), the two-day conference in March will put the spotlight on issues regarding the creation of medicines for children aged 0 to 16, in addition to the step-change in clinical trials involving young people.

LAVAL, Quebec, January 14 /PRNewswire/ -- BioSyntech, Inc. (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced that it will conclude enrolment next month for the Canadian-European pivotal trial of its cartilage repair device, BST-CarGel(R). To date, the Company has enrolled more than 70 subjects and participating clinical sites will be permitted to enrol additional subjects until February 10th, 2009.

PARIS, January 14 /PRNewswire/ -- Kewego, the European leader in management, broadcasting and monetisation solutions for videos on the Internet, intranets and screen networks, announces fundraising of 4.7m Euros subscribed by the company's historic shareholders: Banexi Venture Partners and CDC Entreprises, a subsidiary of Caisse des Depots et Consignations (through the France Investissements team).

MUNICH, Germany, January 14 /PRNewswire/ -- Europe's leading digital innovation conference, DLD (Digital Life Design), is taking place from 25 to 27 January 2009 in Munich for the fifth year. Around 800 selected entrepreneurs, thinkers and creative leaders from a variety of sectors will gather at this synergy exchange at the invitation of Hubert Burda Media. All panels at the English speaking conference will also be broadcast on the DLD video portal (http://www.dld-conference.com).

MOUNTAIN VIEW, California, January 14 /PRNewswire/ --

- High-Quality USB 2.0 nanoPHY IP Delivers Exceptionally High Yield, Small Area, and Low Power Consumption for Advanced WiMAX Mobile Station

NOTTINGHAM, England, January 14 /PRNewswire/ --

- National Study Finds That 6 in 10 (and Two-Thirds of Men) Have Spent Nothing on Eye Health in the Last Year

- Vision Express to Offer a Comprehensive Programme of National Eye Health Initiatives in 2009, Including:

- Partnership With UCL Institute of Ophthalmology to Improve Effectiveness of Front Line Identification of Eye-Related Conditions - Major Education Programme Targeted at Schools to Promote Better Eye Care and More Regular Testing - Completion of GBPMulti-Million Investment in New High-Tech Digital Retinal Scanning Equipment Throughout 300-Strong Vision Express Network

- Proper Eye Care is Essential for the High Definition Age Says Vision Express Ceo

LONDON, January 14 /PRNewswire/ -- Unite, the UK's biggest union, has today repeated its call to the Government to be bold and give the go-ahead for the third runway, stating that expansion in the best interest of the UK and its transport system.

Unite members who work in airports across the UK will today take the case for the modernisation of Heathrow to Parliament. The union is becoming increasingly concerned that further delay on Heathrow's third runway sends a signal to EU competitors that the UK is not committed to improving its transport infrastructure.

SINGAPORE and HAMBURG, Germany, January 14 /PRNewswire/ -- Singapore-based International Refinery Services Pte Ltd (IRS) is the latest addition to Germanischer Lloyd (GL). With the acquisition of the asset management expert company, the GL Group expands its service portfolio for the petroleum, oil and gas industry yet again.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090114/334756 )

LONDON, January 14 /PRNewswire/ --

The vaccines market, which was earlier associated with low profit margins and slow growth rates, has gained momentum in recent years through innovation. The introduction of novel vaccines for diseases with high burden and continuous investments aimed at boosting production capacity is driving the growth of this previously unattractive market.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost Sullivan (http://www.pharma.frost.com), European Vaccines Market, finds that the market earned revenues of $4.50 billion in 2007 and estimates this to reach $9.85 billion in 2014.